Literature DB >> 21651923

Effects of corticotropin releasing factor (CRF) on sleep and body temperature following controllable footshock stress in mice.

L Yang1, L L Wellman, X Tang, L D Sanford.   

Abstract

Rapid eye movement sleep (REM) is increased after controllable stress (modeled by escapable footshock, ES) and decreased after uncontrollable stress (modeled by inescapable footshock, IS). Decreases in REM after IS are exacerbated by corticotropin releasing factor (CRF) and attenuated by a CRF antagonist. In this study, we trained mice with ES following injections of CRF, astressin (AST), or saline (SAL) to determine whether CRF would alter REM after ES. Male BALB/cJ mice (n=7) were implanted for recording sleep, activity and body temperature via telemetry and with a guide cannula aimed into a lateral ventricle. After recovery from surgery, sleep following exposure to a novel chamber was recorded as a handling control (HC). The mice received one day of training with ES without injection followed by weekly training sessions in which they received counterbalanced intracerebroventricular (ICV) microinjections of either SAL or CRF (days 7 & 14) or SAL or AST (days 21 & 28) prior to ES. On each experimental day, sleep was recorded for 20 h. Compared to HC, the mice showed significantly increased REM when receiving either SAL or AST prior to ES whereas CRF prior to ES significantly reduced REM. Stress-induced hyperthermia had longer duration after ES compared to HC, and was not significantly altered by CRF or AST compared to SAL. The current results demonstrate that activity in the central CRF system is an important regulator of stress-induced alterations in REM.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21651923      PMCID: PMC3175331          DOI: 10.1016/j.physbeh.2011.05.025

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  70 in total

1.  Sleep complaints as early predictors of posttraumatic stress disorder: a 1-year prospective study of injured survivors of motor vehicle accidents.

Authors:  Danny Koren; Isaac Arnon; Peretz Lavie; Ehud Klein
Journal:  Am J Psychiatry       Date:  2002-05       Impact factor: 18.112

2.  Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder.

Authors:  J D Bremner; J Licinio; A Darnell; J H Krystal; M J Owens; S M Southwick; C B Nemeroff; D S Charney
Journal:  Am J Psychiatry       Date:  1997-05       Impact factor: 18.112

3.  Rat strain differences suggest a role for corticotropin-releasing hormone in modulating sleep.

Authors:  M R Opp
Journal:  Physiol Behav       Date:  1997-12-31

4.  Effect of intracerebroventricular administration of alpha-helical CRH (9-41) on the sleep/waking cycle in rats under normal conditions or after subjection to an acute stressful stimulus.

Authors:  M M González; J L Valatx
Journal:  J Sleep Res       Date:  1997-09       Impact factor: 3.981

5.  Evidence that brief stress may induce the acute phase response in rats.

Authors:  T Deak; J L Meriwether; M Fleshner; R L Spencer; A Abouhamze; L L Moldawer; R E Grahn; L R Watkins; S F Maier
Journal:  Am J Physiol       Date:  1997-12

Review 6.  The psychobiological basis of posttraumatic stress disorder.

Authors:  C Grillon; S M Southwick; D S Charney
Journal:  Mol Psychiatry       Date:  1996-09       Impact factor: 15.992

7.  Role of corticotropin-releasing hormone in stressor-induced alterations of sleep in rat.

Authors:  Fang-Chia Chang; Mark R Opp
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-08       Impact factor: 3.619

8.  Telemetric recording of sleep and home cage activity in mice.

Authors:  Xiangdong Tang; Larry D Sanford
Journal:  Sleep       Date:  2002-09-15       Impact factor: 5.849

9.  Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites: substrate for the co-ordination of emotional and cognitive limbs of the stress response.

Authors:  E J Van Bockstaele; E E Colago; R J Valentino
Journal:  J Neuroendocrinol       Date:  1998-10       Impact factor: 3.627

10.  REM sleep and the early development of posttraumatic stress disorder.

Authors:  Thomas A Mellman; Victoria Bustamante; Ana I Fins; Wilfred R Pigeon; Bruce Nolan
Journal:  Am J Psychiatry       Date:  2002-10       Impact factor: 18.112

View more
  6 in total

1.  Bmal1 knockdown suppresses wake and increases immobility without altering orexin A, corticotrophin-releasing hormone, or glutamate decarboxylase.

Authors:  Afaf Akladious; Sausan Azzam; Yufen Hu; Pingfu Feng
Journal:  CNS Neurosci Ther       Date:  2018-02-14       Impact factor: 5.243

2.  Basolateral amygdala and the regulation of fear-conditioned changes in sleep: role of corticotropin-releasing factor.

Authors:  Laurie L Wellman; Linghui Yang; Marta A Ambrozewicz; Mayumi Machida; Larry D Sanford
Journal:  Sleep       Date:  2013-04-01       Impact factor: 5.849

3.  Hypocretin in median raphe nucleus modulates footshock stimuli-induced REM sleep alteration.

Authors:  Yi-Tse Hsiao; Yun Lo; Pei-Lu Yi; Fang-Chia Chang
Journal:  Sci Rep       Date:  2019-06-03       Impact factor: 4.379

4.  Effects of corticotropin releasing factor (CRF) on sleep and temperature following predictable controllable and uncontrollable stress in mice.

Authors:  Laurie L Wellman; Linghui Yang; Larry D Sanford
Journal:  Front Neurosci       Date:  2015-07-30       Impact factor: 4.677

5.  Dopaminergic inhibition by G9a/Glp complex on tyrosine hydroxylase in nerve injury-induced hypersensitivity.

Authors:  Nan Wang; Xiaofeng Shen; Senzhu Bao; Shan-Wu Feng; Wei Wang; Yusheng Liu; Yiquan Wang; Xian Wang; Xirong Guo; Rong Shen; Haibo Wu; Liming Lei; Shiqin Xu; Fuzhou Wang
Journal:  Mol Pain       Date:  2016-08-24       Impact factor: 3.395

Review 6.  New Insights into the Role of Glutathione in the Mechanism of Fever.

Authors:  Sylwia Wrotek; Justyna Sobocińska; Henryk M Kozłowski; Małgorzata Pawlikowska; Tomasz Jędrzejewski; Artur Dzialuk
Journal:  Int J Mol Sci       Date:  2020-02-19       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.